N-T-Boc-Pyrrole

How Boc Protection Directs Regioselective Cross-Coupling in Kinase Inhibitor Synthesis

In large-scale cGMP manufacturing of Type II kinase inhibitors structurally related to sunitinib and regorafenib, the introduction of an intact pyrrole scaffold via late-stage cross-coupling imposes stringent requirements on nitrogen protection strategy. Unprotected pyrrole undergoes irreversible N-arylation under the same catalytic conditions intended for C-2 or C-3 functionalization, generating regioisomeric impurities that persist through downstream processing and challenge column purification at production volumes. N-T-Boc-pyrrole is charged as a 1.05–1.30 molar equivalent relative to the aryl halide coupling partner in a Pd(OAc)₂/SPhos catalytic system, dissolved in degassed tetrahydrofuran and aqueous potassium carbonate (2 M) at a volumetric ratio of 4:1. Process-scale batches executed in 2000-L glass-lined reactors equipped with retreat-curve impeller agitation at 120–140 rpm require jacket temperature control of 75 ± 3 °C for 14–18 hours. Upon reaction completion confirmed by in-process HPLC (C18 column, 254 nm detection, retention time window for the coupled intermediate between 7.2 and 8.1 min under gradient elution of acetonitrile/0.1% trifluoroacetic acid), the mixture is cooled to 20 °C, filtered through a 0.5-µm polypropylene cloth to remove palladium black, and subjected to a solvent switch to methanol for crystallization. The Boc deprotection is performed by adding concentrated hydrochloric acid (37 wt%, 1.8–2.2 equivalents relative to the Boc group) at 0–5 °C with vigorous agitation to prevent localized overheating and pyrrole ring degradation; off-gassing of carbon dioxide and isobutylene is controlled through a chilled condenser train vented through a caustic scrubber. The resulting pyrrole-aryl intermediate is isolated as a hydrochloride salt through isopropyl alcohol antisolvent addition, yielding a purity exceeding 99.0% by HPLC area percent. Regulatory compliance demands adherence to ICH Q7 for active pharmaceutical ingredient GMPs, with residual solvent limits per USP <467> (particularly Class 2 solvents tetrahydrofuran ≤ 720 ppm and methanol ≤ 3000 ppm) and palladium content controlled to ≤ 10 µg/g via inductively coupled plasma mass spectrometry per USP <233>. A pre-validation impurity profiling study must quantify the des-Boc pyrrole dimer and N-alkylated byproducts at trace levels using a high-resolution mass spectrometry method per ICH Q3A thresholds. The primary terminal product from this intermediate is the free base or malate salt of a multi-targeted tyrosine kinase inhibitor for oncology indications, with specifications conforming to individual pharmacopoeial monographs (USP, EP, or JP) where monographed.

Electropolymerized N-Boc-Pyrrole Films: Controlled Deblocking and Dopant Retention

Fabrication of adherent polypyrrole thin films on indium tin oxide (ITO) substrates via chronoamperometry exploits the steric and electronic influence of the N-Boc substituent to modify polymer backbone order and subsequent dedoping kinetics. A three-electrode single-compartment cell is assembled with an ITO working electrode (10 Ω/sq sheet resistance), a platinum mesh counter electrode, and a Ag/AgCl (3 M NaCl) reference electrode. The electrolyte consists of N-T-Boc-pyrrole dissolved at 0.35–0.55 M in anhydrous propylene carbonate containing 0.1 M tetrabutylammonium hexafluorophosphate as supporting electrolyte. The addition level is selected to balance solution viscosity and mass transport limitations; concentrations exceeding 0.60 M result in non-uniform film thickness and edge cracking observed during post-deposition thermal annealing at 120 °C for 30 minutes. Electrochemical deposition is conducted potentiostatically at +1.35 V versus the reference electrode for 600–1200 seconds, yielding films of 0.8–2.5 µm thickness measured by stylus profilometry in accordance with ISO 4287:1997. The Boc-protected film exhibits a conductivity on the order of 10⁻³ S/cm before deprotection, rising to 0.5–2 S/cm after controlled hydrolytic removal. Deblocking is achieved by immersing the film in a 0.1 M solution of methanesulfonic acid in a tetrahydrofuran/water mixture (9:1 v/v) at 40 °C for 2 hours without delamination, as monitored by the disappearance of the characteristic carbonyl stretching band at 1745 cm⁻¹ in reflection–absorption infrared spectroscopy. Process failure modes include bubble entrapment during polymerization when the electrolyte is not pre-degassed with argon for ≥ 45 minutes, and overoxidation of the pyrrole ring if the cut-off charge density surpasses 100 mC/cm², leading to irreversible loss of electroactivity. Regulatory benchmarks for finished electrode devices reference the RoHS Directive 2011/65/EU Annex II substance restrictions and IEC 62321-3-1:2013 for determination of halogens when the film is integrated into printed electronic assemblies. The terminal configuration is a flexible interdigitated sensor electrode for sweat electrolyte monitoring, certified under ISO 10993-5:2009 for in vitro cytotoxicity if the device is skin-contacting, with surface resistance measured per ASTM D257-14.

Synthesis of meso-substituted porphyrins for photodynamic therapy typically relies on acid-catalysed condensation of pyrrole derivatives with aromatic aldehydes, where N-T-Boc-pyrrole serves as a masked synthon to prevent irreversible N-protonation side reactions that otherwise produce non-porphyrinogenic polypyrrolic oligomers. In a modified Lindsey protocol scaled to 5-L three-necked round-bottom flasks under nitrogen atmosphere, a 1.0 molar equivalent of N-T-Boc-pyrrole is combined with 0.5 molar equivalents of the functionalized benzaldehyde in dichloromethane (final concentration of pyrrole species: 0.18 M) and protected from light. The addition level must be tightly controlled because an excess of pyrrole component beyond 1.05 equivalents raises the statistical formation of the N-Boc porphyrinogen intermediate but complicates the chromatographic removal of uncyclized dipyrromethane byproducts. Boron trifluoride diethyl etherate (0.33 equivalents relative to pyrrole) is introduced as a Lewis acid catalyst at −5 °C with continuous stirring for 90 minutes, followed by oxidation with 2.2 equivalents of 2,3-dichloro-5,6-dicyano-1,4-benzoquinone at ambient temperature for 18 hours to afford the protected porphyrinogen macrocycle. The crude mixture is filtered through a short alumina plug to remove quinone hydroquinone residues and concentrated to a dark purple solid. The subsequent one-pot dual deprotection and zinc or aluminum metalation procedure involves treatment with excess trifluoroacetic acid (12 equivalents) in dichloromethane for 12 hours at 25 °C to cleave the Boc groups, followed by neutralization with triethylamine and insertion of the metal ion using the corresponding acetate salt in a refluxing chloroform/methanol system. Terminal photosensitizers intended for clinical use must satisfy residual solvent requirements of ICH Q3C under a risk-based justification and are subject to elemental impurity limits per USP <232>/<233> when synthesized at registered API grade. For medical device classifications, a batch release specification may incorporate ISO 10993-1:2018 biological evaluation endpoints for local effects after intravenous administration, and the active compound purity is set at ≥ 99.5% with any single impurity not exceeding 0.10% as determined by a validated HPLC method with photodiode array detection at 420 nm.

When N-T-Boc-Pyrrole Replaces Hazardous Halogenated Solvents in Agrochemical Intermediate Routes

Certain amide-linked fungicide scaffolds derived from 1-methyl-3-(trifluoromethyl)-1H-pyrazole-4-carbonyl precursors require a pyrrole-2-carboxylic acid building block that must be introduced without concomitant N-methylation contamination. Historically, routes utilizing neat pyrrole in dichloromethane under stoichiometric oxidant conditions generate wastewater streams with high adsorbable organic halogen (AOX) loads, triggering non-compliance with industrial effluent directives such as the EU Industrial Emissions Directive 2010/75/EU and related BAT conclusions for organic fine chemical manufacturing. The insertion of N-T-Boc-pyrrole enables a greener coupling protocol: the protected pyrrole (1.15–1.25 equivalents) is lithiated at the −78 °C setpoint of a liquid nitrogen/acetone bath in a 100-L cryogenic reactor using n-butyllithium (2.5 M in hexanes, 1.05 equivalents) in anhydrous 2-methyltetrahydrofuran under a dry air atmosphere with moisture monitored at ≤ 10 ppm via in-line NIR spectroscopy. The resulting 2-lithio-N-Boc-pyrrole solution is cannulated into a second reactor containing crushed dry ice to yield the corresponding carboxylic acid after acidic workup with 10 wt% aqueous citric acid to a pH of 3.0–3.5. The crude acid is isolated by filtration and recrystallized from ethyl acetate/cyclohexane (1:3 v/v) with a recovery of 78–84% and a purity of ≥ 97% by ¹H NMR integration. In the subsequent amide bond formation, 1.0 equivalent of the N-Boc-pyrrole-2-carboxylic acid is activated with 1.1 equivalents of 1-ethyl-3-(3-dimethylaminopropyl)carbodiimide hydrochloride and 1.1 equivalents of 1-hydroxybenzotriazole in dimethylformamide at 0 °C, then combined with the amine component in a single liquid-phase addition. After aqueous workup and solvent swap to methanol, the bis-Boc protected intermediate precipitates upon addition of water. The global regulatory dossier for the resulting fungicide technical concentrate requires compliance with the FAO/WHO Joint Meeting on Pesticide Specifications CIPAC Handbook J methods for identity and content, and the final active ingredient must meet the threshold of ≤ 0.1% individual unspecified impurity as established under EC Regulation 1107/2009 Annex II data requirements. Published data for long-term storage stability of N-T-Boc-pyrrole under tropical warehouse conditions (40 ± 2 °C, 75 ± 5% RH) in original HDPE unopened packaging indicates ≤ 1.2% decomposition after 90 days, primarily to the des-Boc product, as determined by GC-FID with an HP-5 capillary column.

Preparing high-purity hole-transporting materials (HTMs) for vacuum-deposited OLED stacks demands monomers with sub-10 ppm metal ion content and absence of nitrogen-protecting group residues that could outgas during sublimation at 200–400 °C under 10⁻⁷ mbar. N-T-Boc-pyrrole is utilized as a masked nucleophilic component in the construction of tetraarylbenzidine and spirobifluorene-cored HTMs through palladium-catalyzed C–N coupling with brominated triarylamines. On a 5-g scale preparation intended for pilot device fabrication, the catalyst loading is set to 0.8 mol% tris(dibenzylideneacetone)dipalladium(0) and 1.6 mol% 2-dicyclohexylphosphino-2′,6′-dimethoxybiphenyl (SPhos) relative to the aryl bromide limiting reagent, with N-T-Boc-pyrrole charged at 1.02–1.08 equivalents to suppress homocoupling byproducts. The reaction proceeds in toluene with sodium tert-butoxide base (1.3 equivalents) under argon flow in a 100-mL Schlenk tube submerged in an oil bath at 105 °C for 6 hours. After Celite filtration and solvent removal, the Boc deprotection is conducted in a dedicated sublimation-grade environment using solid p-toluenesulfonic acid monohydrate (0.2 equivalents) in 1,4-dioxane at 70 °C, monitored by thin-layer chromatography on silica gel 60 F₂₅₄ plates. The free pyrrole-terminated intermediate precipitates from hexane, and is further purified by temperature-gradient vacuum sublimation in a custom-designed horizontal glass tube oven with three independently controlled heating zones (Zone 1: 180 °C, Zone 2: 210 °C, Zone 3: 25 °C) to obtain single-crystalline material of ≥ 99.99% purity as assessed by differential scanning calorimetry extrapolated onset melting point and high-performance liquid chromatography with fluorescence detection. The purified HTM is co-deposited with a phosphorescent emissive dopant such as tris(2-phenylpyridine)iridium(III) onto ITO-glass substrates, requiring that the finished material pass inductively coupled plasma mass spectrometry screening per ASTM E2823-17 for iron, nickel, and chromium, each not exceeding 2 ppm. The operational lifetime of the resulting OLED device, measured as T₉₅ at an initial luminance of 4000 cd/m² under constant current driving conditions, is directly correlated with the absence of pyrrole N–H oxidative degradation signals detectable at 1695 cm⁻¹ in Raman microscopy of aged electron donor layers.

Lamellarin Alkaloid Total Synthesis: Boc-Pyrrole as a Latent Nucleophile in Bischler–Napieralski-Type Cyclizations

Construction of the fused pentacyclic lamellarin D core for marine alkaloid analogues with submicromolar cytotoxicity against multi-drug-resistant cancer cell lines necessitates a pyrrole synthon that withstands strongly electrophilic conditions during isoquinoline annulation. The N-Boc group functions as a temporary inactivator of the pyrrole nitrogen, preventing its participation as a nucleophile in undesired intermolecular alkylation when 1,2,3,4-tetrahydroisoquinoline precursors are treated with phosphorous oxychloride at 110 °C under microwave irradiation in a sealed vessel. The total synthesis route commences with attachment of the N-Boc-pyrrole unit through a copper(I)-mediated azide–alkyne cycloaddition to a preformed acetylene-bearing veratrole derivative, consuming 1.0 equivalent of the protected pyrrole and 0.95 equivalents of the azide in the presence of 5 mol% copper(I) iodide in tert-butanol/water (1:1) at 50 °C for 24 hours. Following chromatographic purification, the key Bischler–Napieralski cyclization employing excess POCl₃ (8 equivalents) in anhydrous acetonitrile proceeds within 20 minutes to yield the Boc-protected hexacyclic intermediate. Critical process limits include the mandatory quenching of the POCl₃ mixture into crushed ice at ≤ 5 °C within 30 seconds of the reactor being opened; a delay beyond 90 seconds results in an exothermic degradation cascade that reduces the isolated yield to below 15%. The terminal deprotection of the Boc group is deferred to the final step, using 4 N hydrogen chloride in 1,4-dioxane (12 equivalents relative to Boc) at ambient temperature for 4 hours, deliberately avoiding elevated temperatures which would cause cleavage of the lactone ring linking the D and E rings of lamellarin. All laboratory-scale batch records are structured to align with ISO 9001:2015 clause 8.5.1 controlled production provisions when subsequent scale-up to 100-g lot size is executed in a multi-purpose pilot facility qualified for cytotoxic compound handling with negative-pressure isolator containment of −50 Pa differential. The target compound is purified by reversed-phase preparative HPLC (C18 column, acetonitrile/water gradient with 0.05% trifluoroacetic acid) to >98.5% purity and is designated as a research-grade reference standard for in vivo xenograft efficacy studies under institutional animal use protocols, not a commercial API at this stage of development.